Scientific Sessions 2024  /  EHJ and Circulation: Advances in 2024  /  The Year in Cardiometabolic Diseases
Logo

American Heart Association

  2
  0

Final ID:

The Year in Cardiometabolic Diseases

  • Verma, Subodh  ( ST MICHAELS HOSPITAL , Toronto , Ontario , Canada )
  • Consentino, Francesco  ( Karolinska Institutet , Stockholm , Sweden )
  • Mcguire, Darren  ( UT Southwestern , Dallas , Texas , United States )
    • Author Disclosures:
    Subodh Verma: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Amarin (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Sanofi (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):S & L Solutions Event Management Inc. (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):PhaseBio (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Pfizer (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Novo Nordisk (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Novartis (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Janssen (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):HLS Therapeutics (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Eli Lilly (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Canadian Medical and Surgical Knowledge Translation Research Group (Speaker & Consultant):Active (exists now) ; Research Funding (PI or named investigator):Boehringer Ingelheim (Speaker & Consultant):Active (exists now) ; Research Funding (PI or named investigator):Bayer (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):AstraZeneca (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Amgen (Speaker & Consultant):Active (exists now) | Francesco Consentino: DO have relevant financial relationships ; Speaker:Novo Nordisk:Past (completed) ; Advisor:Pfizer:Past (completed) ; Speaker:Pfizer:Past (completed) ; Speaker:MSD:Past (completed) ; Speaker:BMS:Past (completed) ; Speaker:Berlin Chemie:Past (completed) | Darren McGuire: DO have relevant financial relationships ; Researcher:Novo Nordisk:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:Intercept:Active (exists now) ; Consultant:Altimmune:Active (exists now) ; Consultant:Lexicon:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:NovoNordisk:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Lilly USA:Active (exists now) ; Researcher:Esperion:Past (completed) ; Researcher:AstraZeneca:Past (completed) ; Researcher:NewAmsterdam:Active (exists now) ; Researcher:Boehringer Ingelheim:Active (exists now) ; Researcher:Pfizer:Active (exists now) ; Researcher:Lilly USA:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

EHJ and Circulation: Advances in 2024

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
The Year in Cardiovascular Imaging

Bucciarelli-ducci Chiara, Delgado Victoria

The Year in Cardio-oncology

Lopez-fernandez Teresa, Zaha Vlad

More abstracts from these authors:
Will Future Trials Help Us SURPASS Our Understanding of Diabetes Management?

Taub Pam, Green Jennifer, Mcguire Darren

Discussant: SELECT

Mcguire Darren, Neeland Ian

You have to be authorized to contact abstract author. Please, Login
Not Available